Related Experiment Video
Updated: Mar 21, 2026

08:36
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
1.7K
Atypical Dermatophytosis in Patients Treated by JAK Inhibitors
Jen A Barak Levitt1,2, Nurit Kulish1,2, Mira Hamed1,2
1Department of Dermatology, Emek Medical Center, Afula, Israel.
Experimental Dermatology
|March 20, 2026
Summary
Janus kinase (JAK) inhibitors, used for immune diseases, may increase fungal infection risk. This study highlights five cases of atypical dermatophytosis in patients taking JAK inhibitors, emphasizing the need for clinical vigilance.
Area of Science:
- Dermatology
- Immunology
- Pharmacology
Background:
- Janus kinase (JAK) inhibitors modulate the JAK-STAT pathway for immune-mediated diseases.
- While effective, JAK inhibitors can impair immune responses, including antifungal defenses.
Purpose of the Study:
- To report and analyze five cases of atypical dermatophyte infections in patients treated with JAK inhibitors (baricitinib or upadacitinib).
- To highlight the clinical presentations and presumed effects of JAK inhibitors on fungal infections.
Main Methods:
- Case series summarizing clinical presentations and treatment regimens.
- Identification of causative fungi using Polymerase Chain Reaction (PCR) and fungal cultures.
- Analysis of patient responses to systemic antifungal agents and JAK inhibitor dosage adjustments.
Main Results:
- Patients presented with unusual erythematous plaques, papules, and scaling lesions.
- Infections were confirmed as Trichophyton tonsurans, T. rubrum, T. verrucosum, and Microsporum canis.
- Systemic antifungals (terbinafine, itraconazole, griseofulvin) were effective; some cases required JAK inhibitor dose reduction.
Conclusions:
- JAK inhibitors may alter the presentation of dermatophytosis, potentially delaying diagnosis.
- Clinicians must maintain vigilance for cutaneous fungal infections in patients on JAK inhibitors, especially with new rashes.
- The immunomodulatory effects of JAK inhibitors necessitate careful monitoring for opportunistic infections.
Related Concept Videos
Antifungal Agents
1
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
1
The JAK-STAT Signaling Pathway
13.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.7K
Skin Diseases and Disorders
6.1K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
6.1K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
655
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
655
Immunodeficiency Diseases
2.7K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
2.7K
Fungal Phylum Microsporidia
681
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
681

